{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental%3A+Test+Product+1&page=2", "query": { "intervention": "Experimental: Test Product 1", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 160, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental%3A+Test+Product+1&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Experimental%3A+Test+Product+1&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T11:00:55.667Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04727528", "title": "Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperkalaemia", "Metabolic Acidosis", "Chronic Kidney Disease" ], "interventions": [ { "name": "Sodium zirconium cyclosilicate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 39, "start_date": "2021-03-22", "completion_date": "2022-09-14", "has_results": true, "last_update_posted_date": "2023-10-06", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 29, "location_summary": "Florence, Alabama • Chula Vista, California • Downey, California + 25 more", "locations": [ { "city": "Florence", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Downey", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "South Gate", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04727528" }, { "nct_id": "NCT04786873", "title": "A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Growth Hormone Deficiency" ], "interventions": [ { "name": "Macimorelin", "type": "DRUG" }, { "name": "Arginine", "type": "DIAGNOSTIC_TEST" }, { "name": "Clonidine", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "AEterna Zentaris", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 101, "start_date": "2021-11-16", "completion_date": "2024-06-13", "has_results": false, "last_update_posted_date": "2024-08-12", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 12, "location_summary": "Tucson, Arizona • Greenwood Village, Colorado • St. Petersburg, Florida + 9 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boise", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT04786873" }, { "nct_id": "NCT01046084", "title": "Lansoprazole 30 mg DR Capsule Replicate Food Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Lansoprazole", "type": "DRUG" }, { "name": "Prevacid®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2003-08", "completion_date": "2003-09", "has_results": true, "last_update_posted_date": "2010-12-08", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01046084" }, { "nct_id": "NCT03804476", "title": "Phase 1 Study to Assess AER-271", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Stroke", "Stroke, Acute", "Stroke, Ischemic" ], "interventions": [ { "name": "AER-271", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aeromics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 80, "start_date": "2018-06-26", "completion_date": "2019-08-28", "has_results": false, "last_update_posted_date": "2020-07-09", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03804476" }, { "nct_id": "NCT05358704", "title": "Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer of Rectum" ], "interventions": [ { "name": "combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2022-05-13", "completion_date": "2028-01-30", "has_results": false, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 5, "location_summary": "Lakewood, New Jersey • Livingston, New Jersey • New Brunswick, New Jersey + 2 more", "locations": [ { "city": "Lakewood", "state": "New Jersey" }, { "city": "Livingston", "state": "New Jersey" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Somerset", "state": "New Jersey" }, { "city": "Toms River", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05358704" }, { "nct_id": "NCT02234934", "title": "Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Granulomatous Disease, Chronic, X-linked" ], "interventions": [ { "name": "Lentiviral G1XCGD Gene Therapy", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "23 Months", "maximum_age": null, "sex": "MALE", "summary": "23 Months and older · Male only" }, "enrollment_count": 10, "start_date": "2015-10-29", "completion_date": "2024-12-01", "has_results": false, "last_update_posted_date": "2025-05-02", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 3, "location_summary": "Los Angeles, California • Bethesda, Maryland • Boston, Massachusetts", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02234934" }, { "nct_id": "NCT03267511", "title": "A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oral Hygiene" ], "interventions": [ { "name": "5% KNO3 / 0.2542% NaF dentifrice with 0.5% spherical silica", "type": "DRUG" }, { "name": "5% KNO3 / 0.2542% NaF dentifrice with 1% spherical silica and 5% STP", "type": "DRUG" }, { "name": "5% KNO3 / 0.2542% NaF dentifrice with 6% abrasive silica", "type": "DRUG" }, { "name": "5% KNO3 / 0.2543% NaF dentifrice with 16% abrasive silica and 5% STP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 123, "start_date": "2017-09-25", "completion_date": "2017-12-02", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 1, "location_summary": "Fort Wayne, Indiana", "locations": [ { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03267511" }, { "nct_id": "NCT03074266", "title": "Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Blood Coagulation Test" ], "interventions": [ { "name": "GEM Hemochron 100 ACT", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Accriva Diagnostics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2017-06-08", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2018-07-26", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 9, "location_summary": "Los Angeles, California • Sacramento, California • Aurora, Colorado + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Takoma Park", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03074266" }, { "nct_id": "NCT03890666", "title": "A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol eMDPI DS", "type": "DRUG" }, { "name": "albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 333, "start_date": "2020-10-26", "completion_date": "2021-10-04", "has_results": true, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Los Angeles, California • Stockton, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03890666" }, { "nct_id": "NCT03512171", "title": "Decision Making Study in Young and Middle-Aged Adults: Part II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adults" ], "interventions": [ { "name": "Dextroamphetamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "[18F]Fallypride", "type": "DIAGNOSTIC_TEST" }, { "name": "[18F]-FE-PE2I", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "20 Years to 65 Years" }, "enrollment_count": 65, "start_date": "2016-03-31", "completion_date": "2018-05-15", "has_results": false, "last_update_posted_date": "2019-06-27", "last_synced_at": "2026-10-01T11:00:55.667Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03512171" } ] }